Evaluation of Lymphoma Prognosis and Survivorship in Recently Diagnosed Patients, LEO Study

Enrolling by invitationOBSERVATIONAL
Enrollment

21,000

Participants

Timeline

Start Date

August 16, 2021

Primary Completion Date

August 1, 2026

Study Completion Date

August 1, 2026

Conditions
Lymphoma, Non-Hodgkin
Trial Locations (10)

10065

Weill Cornell Medical College, New York

14642

University of Rochester Medical Center, Rochester

30322

Winship Cancer Institute of Emory University, Atlanta

33136

University of Miami: Sylvester Comprehensive Cancer Center, Miami

52242

University of Iowa, Iowa City

55902

Mayo Clinic, Rochester

63110

Washington University School of Medicine in St. Louis, St Louis

77030

MD Anderson Cancer Center, Houston

85259

Mayo Clinic in Arizona, Scottsdale

32224-9980

Mayo Clinic in Florida, Jacksonville

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Emory University

OTHER

collaborator

University of Iowa

OTHER

collaborator

M.D. Anderson Cancer Center

OTHER

collaborator

Washington University School of Medicine

OTHER

collaborator

University of Rochester

OTHER

collaborator

Weill Medical College of Cornell University

OTHER

collaborator

University of Miami

OTHER

collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER

NCT04996706 - Evaluation of Lymphoma Prognosis and Survivorship in Recently Diagnosed Patients, LEO Study | Biotech Hunter | Biotech Hunter